Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE165209 | GEO | 2021/05/19

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [HiChIP]

Project description:Hijacking of primitive hematopoietic enhancers, or generation of a neo-enhancer by genomic amplification, results in deregulation of BCL11B as the defining feature of a subset of T/myeloid leukemia. We report H3K27ac and BCL11B binding in these Leukemias.

2021-05-19 | GSE165207 | GEO

Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell Leukemia.

Project description:Lineage-ambiguous leukemias are high-risk malignancies of poorly understood genetic basis. Here, we describe a distinct subgroup of acute leukemia with expression of myeloid, T lymphoid, and stem cell markers driven by aberrant allele-specific deregulation of BCL11B, a master transcription factor responsible for thymic T-lineage commitment and specification. Mechanistically, this deregulation was driven by chromosomal rearrangements that juxtapose BCL11B to superenhancers active in hematopoietic progenitors, or focal amplifications that generate a superenhancer from a noncoding element distal to BCL11B. Chromatin conformation analyses demonstrated long-range interactions of rearranged enhancers with the expressed BCL11B allele and association of BCL11B with activated hematopoietic progenitor cell cis-regulatory elements, suggesting BCL11B is aberrantly co-opted into a gene regulatory network that drives transformation by maintaining a progenitor state. These data support a role for ectopic BCL11B expression in primitive hematopoietic cells mediated by enhancer hijacking as an oncogenic driver of human lineage-ambiguous leukemia. SIGNIFICANCE: Lineage-ambiguous leukemias pose significant diagnostic and therapeutic challenges due to a poorly understood molecular and cellular basis. We identify oncogenic deregulation of BCL11B driven by diverse structural alterations, including de novo superenhancer generation, as the driving feature of a subset of lineage-ambiguous leukemias that transcend current diagnostic boundaries.This article is highlighted in the In This Issue feature, p. 2659.

| S-EPMC8563395 | biostudies-literature

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [ChIP-Seq]

2021-05-19 | GSE165016 | GEO

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [RNA-Seq]

Project description:RNA-seq of BCL11B overexpression in human cord blood CD34+ HSPCs identifies upregulation of T and downregulation of myeloid genes

2021-05-19 | GSE173432 | GEO

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [single-cell multiomics]

2021-05-19 | GSE173319 | GEO

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [single-cell RNA-seq]

2021-05-19 | GSE173320 | GEO

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia

| EGAS00001004810 | EGA

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia

Project description:BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia

| PRJNA693549 | ENA

BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [HiChIP]

Project description:BCL11B enhancer hijacking defines a subtype of lineage ambiguous stem cell leukemia [HiChIP]